FABP4 is a candidate marker of cerebellar liponeurocytomas

Journal of Neuro-Oncology

Volumn 108, Issue 3, 2012, Pages 513-519

  Anghileri, Elena ^a   Eoli, Marica ^a   Paterra, Rosina ^a   Ferroli, Paolo ^a   Pollo, Bianca ^a   Cuccarini, Valeria ^a   Maderna, Emanuela ^a   Tringali, Giovanni ^a   Saini, Marco ^a   Salsano, Ettore ^a   Finocchiaro, Gaetano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Cerebellar liponeurocytoma; FABP4; Medulloblastoma

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NEUROG1; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; BRAIN CELL; CELL DIFFERENTIATION; CELL GRANULE; CELL TRANSFORMATION; CEREBELLAR LIPONEUROCYTOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; FATTY ACID BINDING PROTEIN 4 GENE; FEMALE; GENE; GENE LOCATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; MEDULLOBLASTOMA; NEURAL STEM CELL; NEUROEPITHELIOMA; NEUROG1 GENE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; TUMOR CELL; TUMOR GENE;

ADULT; CEREBELLAR NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOMA; MIDDLE AGED; NEUROCYTOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84864073539     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0853-0     Document Type: Review

References (24)

1. Kleihues P, Chimelli L, Giangaspero F (2000) Cerebellar lipo-neurocytoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 110-111
2. Kleihues P, Chimelli L, Giangaspero F, Ohgaki H (2007) Cere-bellar liponeurocytoma. In: Kleihues P, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC Press, Lyon, pp 110-112
3. Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, Weller RO, Taddei GL, Conti R, Del Bigio MR, González-Cámpora R, Radhakrishnan VV, Söy-lemezoglu F, Uro-Coste E, Qian J, Kleihues P, Ohgaki H (2004) Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathol 14(3):281-289 (Pubitemid 39095990)
4. Chakraborti S, Mahadevan A, Govindan A, Yasha TC, Santosh V, Kovoor JM, Ramamurthi R, Alapatt JP, Hedge T, Shankar SK (2011) Supratentorial and cerebellar liponeurocytomas: report of four cases with review of literature. J Neurooncol 103(1): 121-127
5. Owler BK, Makeham JM, Shingde M, Besser M (2005) Cere-bellar liponeurocytoma. J Clin Neurosci 12:326-329
6. Buccoliero AM, Caldarella A, Bacci S, Gallina P, Taddei A, Di Lorenzo N, Romagnoli P, Taddei GL (2005) Cerebellar lipo-neurocytoma: morphological, immunohistochemical, and ultra-structural study of a relapsed case. Neuropathology 25(1):77-83 (Pubitemid 40477715)
7. Châtillon CE, Guiot MC, Roberge D, Leblanc R (2009) Cere-bellar liponeurocytoma with high proliferation index: treatment options. Can J Neurol Sci 36:658-661
8. Limaiem F, Bellil S, Chelly I, Bellil K, Mekni A, Jemel H, Haouet S, Zitouna M, Kchir N (2009) Recurrent cerebellar liponeurocytoma with supratentorial extension. Can J Neurol Sci 36(5):662-665
9. Sharma MC, Agarwal M, Suri A, Gaikwad S, Mukhopadhyay P, Sarkar C (2002) Lipomedulloblastoma in child: a controversial entity. Human Pathol 33(5):564-569
10. Aker FV, Ozkara S, Eren P, Peker O, Armagan S, Hakan T (2005) Cerebellar liponeurocytoma/lipidized medulloblastoma. J Neurooncol 71:53-59
11. Patel N, Fallah A, Provias J, Jha NK (2009) Cerebellar lipo-neurocytoma. Can J Surg 52(4):E117-E119
12. Hortobágyi T, Bódi L, Lantos PL (2007) Adult cerebellar lipo-neurocytoma with predominant pilocytic pattern and myoid dif-ferentiation. Neuropathol Appl Neurobiol 33:121-125 (Pubitemid 46090316)
13. Jenkinson MD, Bosma JJ, Du Plessis D, Ohgaki H, Kleihues P, Warnke P, Rainov NG (2003) Cerebellar liponeurocytoma with an unusually aggressive clinical course: case report. Neurosur-gery 53(6):1425-1427
14. Gross E, Kiechle M, Arnold N (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods 47: 73-81 (Pubitemid 32155477)
15. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
16. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC; United Kingdom Children's Cancer Study Group Brain Tumour Committee (2005) beta-Cate-nin status predicts a favourable outcome in childhood medullo-blastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23(31): 7951-7957 (Pubitemid 46657395)
17. Soylemezoglu F, Soffer D, Onol B, Schwechheimer K, Kleihues P (1996) Lipomatous medulloblastoma in adults. a distinct clin-icopathological entity. Am J Surg Pathol 20(4):413-418 (Pubitemid 26113346)
18. Goldowitz D, Hamre K (1998) The cells and molecules that make a cerebellum. Trends Neurosci 21:375-382 (Pubitemid 28384554)
19. Salsano E, Croci L, Maderna E, Lupo L, Pollo B, Giordana MT, Consalez GG, Finocchiaro G (2007) Expression of the neurogenic basic helix-loop-helix transcription factorNEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro Oncol 9(3):298-307 (Pubitemid 47169662)
20. Cataltepe O, Arikan MC, Ghelfi E, Karaaslan C, Ozsurekci Y, Dresser K Li Y, Smith TW, Cataltepe S (2011) Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma. Neuropathol Appl Neurobiol. doi:10.1111/j.1365-2990.2011.01237.x
21. Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, BischoffJ, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J (official publication of the Feder-ation of American Societies for Experimental Biology) 23: 3865-3873
22. Kawai M, Rosen CJ (2010) PPARy: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6(11):629-636
23. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ (2011) A role for central nervous system PPAR-y in the regula-tion of energy balance. Nat Med 17(5):623-626
24. Urbanska K, Pannizzo P, Grabacka M, Croul S, del Valle L, Khalili K, Reiss K (2008) Activation of PPARβ inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer 123:1015-1024